Nivolumab With Chemotherapy in Refractory MDS

NCT03259516 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Slow recruitment rate

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: Nivolumab
DRUG: Azacitidine
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: all trans retinoic acid
DRUG: Sildenafil
DRUG: Melphalan

Sponsor

St. Petersburg State Pavlov Medical University